The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Alkermes; Ymabs Therapeutics Inc
Phase 1/2 study of elraglusib (9-ING-41), a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, alone or with irinotecan, temozolomide/irinotecan or cyclophosphamide/topotecan in pediatric patients with refractory malignancies: Interim results.
 
Bradley DeNardo
No Relationships to Disclose
 
Jennie Foster
No Relationships to Disclose
 
Navin R. Pinto
No Relationships to Disclose
 
Giselle Linda Saulnier Sholler
No Relationships to Disclose
 
Kieuhoa Tran Vo
No Relationships to Disclose
 
Ami Vijay Desai
Stock and Other Ownership Interests - Pfizer; Viatris
Consulting or Advisory Role - Ology Medical Education; Ymabs Therapeutics Inc
Research Funding - Actuate Therapeutics (Inst); GlaxoSmithKline (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Ymabs Therapeutics Inc (Inst)
 
Jessica Sun
No Relationships to Disclose
 
Lars M. Wagner
No Relationships to Disclose
 
Margaret E Macy
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Bayer (Inst); Ignyta (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Oncternal Therapeutics, Inc (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975
 
Rajen Mody
No Relationships to Disclose
 
Javier E. Oesterheld
Consulting or Advisory Role - Ymabs Therapeutics Inc
Speakers' Bureau - SERVIER
 
Thomas Cash
Honoraria - EUSA Pharma
Consulting or Advisory Role - Y-mAbs Therapeutics
Research Funding - Celgene; Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly; United Therapeutics
 
Roma Bhuta
No Relationships to Disclose
 
Eveline Barbieri
No Relationships to Disclose
 
Andrew DJ Pearson
Consulting or Advisory Role - Celgene; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Celgene; Lilly; Merck; Takeda
 
Ludimila Cavalcante
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Francis J. Giles
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Rishi Ramesh Lulla
No Relationships to Disclose